Skip to content

Cardiogoniometry (CGM) for Early Diagnosis of Acute Coronary Syndromes (ACS)

Cardiogoniometry Zur Früherkennung Akuter Myokardischämien Bei ACS-Symptomatik

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01328795
Acronym
CGM@ACS
Enrollment
249
Registered
2011-04-05
Start date
2009-06-30
Completion date
2010-05-31
Last updated
2011-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

Cardiogoniometry, Chest Pain Unit, ST-elevation, Troponin, Catheter intervention, Fast Track

Brief summary

Aims of the study: Patients in a Chest Pain Unit (CPU) are examined to clarify if the cause of pain is cardiac or not. To identify patients with ST-elevation and other electrocardiogram (ECG) modifications a normal 12-lead ECG is used. The diagnosis non-st-elevation myocardial infarction is determined with the help of the ischemic marker Troponin. However, Troponin levels are elevated earliest 3 to 4 hours after the ischemic event, so that a negative Troponin result at the time of hospital admission is insufficient. Thus the guidelines of the German Society of Cardiology demand a second measurement after 6 to 12 hours. In rare cases false positive Troponin levels have been reported (e.g. in patients with renal insufficiency). The aim of this study is to determine if in the early phase of diagnostic assessment cardiogoniometry can improve differentiation between patients with cardiac (ischemic) emergency and patients with non-cardiac (non-ischemic) cause of pain. Furthermore it will be evaluated if cardiogoniometry is capable to diagnose patients with non-ST-elevation myocardial infarction (NSTEMI) to the same extent as Troponin. This could avoid time loss until a possibly necessary catheter intervention (fast track). To clarify these questions the result of the cardiogoniometry will be compared with the leading diagnosis of the Chest Pain Unit, the diagnosis at hospital discharge as well as with the angiographic findings (as a gold standard). Therefore the performance of cardiac catheterization within 72 hours after start of symptoms is a mandatory inclusion criterion.

Detailed description

The cardiogoniometry vectorcardiography is a procedure that allows a stress-free and non-invasive diagnosis of myocardial ischemia: five thoracic electrodes as well as the heart flow in orthogonal summation vectors are recorded by a computer-assisted method in three dimensions.

Interventions

In the course of the project a cardiogoniometry will be carried out during the ambulant or residential hospitalization before the coronary angiography.

Sponsors

Stiftung Institut fuer Herzinfarktforschung
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * thoracic pain, or pain radiating to neck or arm, or acute dyspnoea * coronary angiography within 72 hours after start of symptoms

Exclusion criteria

* ST elevation myocardial infarction * hemodynamically unstable patients, provided that the application of CGM may lead to an unacceptable delay in diagnosis and therapy * lack of blood samples for troponin determination at admission * patients with cardiac pacemaker * cardiogenic shock * tachycardia (HR \> 100) * \> 50% extra systoles * branch block * atrial fibrillation * no informed consent

Design outcomes

Primary

MeasureTime frameDescription
Difference between cardiogoniometry finding and leading diagnoses of chest pain unit, coronary angiography, and at discharge in assessing the origin of chest pain72 hoursAim is to examine if cardiogoniometry can provide additional information for the decision to perform a diagnostic coronary angiography and if so, which additional value it has. To assess the value of cardiogoniometry its results are compared with the leading diagnosis of the Chest Pain Unit, the diagnosis at hospital discharge as well as with the angiographic findings (as a gold standard).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026